Part 01 - Anidulafungin

This tender concerns the supply of the human medicinal product Anidulafungin. Each vial contains 100 mg of anidulafungin. The reconstituted solution contains 3.33 mg/ml of anidulafungin, and the diluted solution contains 0.77 mg/ml of anidulafungin. The drug belongs to the ATC group J02AX06 and is in the form of powder for concentrate for infusion. The required quantity is 650 packages, each containing one vial, or an equivalent total of 650 vials if packaged differently. This supply is critical for patient treatment requiring this specific antifungal medication.

This is a supplies contract in the health and medical services sector. Located in Slovakia, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 114,277.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.